Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Diuretics should continue to be one of the preferred initial therapies in the management of hypertension: the argument for.

× No keyword cloud information.

44 in total

1. Cardiotoxicity and diuretics: much speculation--little substance.

Authors: G T McInnes; W W Yeo; L E Ramsay; M Moser
Journal: J Hypertens Date: 1992-04 Impact factor: 4.844

Review 2. Suppositions and speculations--their possible effects on treatment decisions in the management of hypertension.

Authors: M Moser
Journal: Am Heart J Date: 1989-12 Impact factor: 4.749

Review 3. Lipid abnormalities and diuretics.

Authors: M Moser
Journal: Am Fam Physician Date: 1989-10 Impact factor: 3.292

4. Primary prevention with metoprolol in patients with hypertension. Mortality results from the MAPHY study.

Authors: J Wikstrand; I Warnold; G Olsson; J Tuomilehto; D Elmfeldt; G Berglund
Journal: JAMA Date: 1988-04-01 Impact factor: 56.272

5. Clinical trials and their effect on medical therapy: the Multiple Risk Factor Intervention Trial.

Authors: M Moser
Journal: Am Heart J Date: 1984-03 Impact factor: 4.749

6. Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT).

Authors: M J Brown; C R Palmer; A Castaigne; P W de Leeuw; G Mancia; T Rosenthal; L M Ruilope
Journal: Lancet Date: 2000-07-29 Impact factor: 79.321

7. The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial.

Authors: Hans Lithell; Lennart Hansson; Ingmar Skoog; Dag Elmfeldt; Albert Hofman; Bertil Olofsson; Peter Trenkwalder; Alberto Zanchetti
Journal: J Hypertens Date: 2003-05 Impact factor: 4.844

8. Treatment of Mild Hypertension Study. Final results. Treatment of Mild Hypertension Study Research Group.

Authors: J D Neaton; R H Grimm; R J Prineas; J Stamler; G A Grandits; P J Elmer; J A Cutler; J M Flack; J A Schoenberger; R McDonald
Journal: JAMA Date: 1993-08-11 Impact factor: 56.272

9. Serum lipoproteins during antihypertensive therapy with beta blockers and diuretics: a controlled long-term comparative trial.

Authors: M Middeke; P Weisweiler; P Schwandt; H Holzgreve
Journal: Clin Cardiol Date: 1987-02 Impact factor: 2.882

10. Multiple risk factor intervention trial. Risk factor changes and mortality results. Multiple Risk Factor Intervention Trial Research Group.

Authors:
Journal: JAMA Date: 1982-09-24 Impact factor: 56.272

3 in total

Review 1. Thiazide effects and adverse effects: insights from molecular genetics.

Authors: David H Ellison; Johannes Loffing
Journal: Hypertension Date: 2009-06-29 Impact factor: 10.190

Review 2. Fixed-dose combinations as initial therapy for hypertension: a review of approved agents and a guide to patient selection.

Authors: Bernard Waeber; François Feihl; Luis M Ruilope
Journal: Drugs Date: 2009 Impact factor: 9.546

3. Development of diabetes with thiazide diuretics: the potassium issue.

Authors: Barry L Carter; Jan Basile
Journal: J Clin Hypertens (Greenwich) Date: 2005-11 Impact factor: 3.738

3 in total